Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to vaginal cells and producing hydrogen peroxide, their use in probiotic compositions and food products and methods for their selection. The invention also relates to the use of said bacteria, metabolites and probiotic compositions for the prevention and/or treatment of urogenital disorders.

Abstract: The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumors, pain, wounds and/or scars.

Abstract: The use of an antibody to a C. albicans cell wall antigen or to a solubilized phosphopeptidomannan (PPM) fraction of the cell wall of C. albicans, or preferably a combination of an IgG2 antibody to a phosphopeptidomannan (PPM) fraction of the cell wall of C. albicans, and an IgG1 or IgG3 antibody to a C. albicans cell wall antigen in the diagnosis of candidiasis or invasive candidiasis is disclosed. Also diagnostic tests are disclosed.

Abstract: The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars.

Abstract: The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars.

Abstract: At least one embodiment of the present invention relates to new peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars.

Abstract: The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides.

Abstract: The use of an antibody to a C albicans cell wall antigen or to a solubilized phosphopeptidomannan (PPM) fraction of the cell wall of C albicans, or preferably a combination of an IgG2 antibody to a phosphopeptidomannan (PPM) fraction of the cell wall of C albicans, and an IgG1 or IgG3 antibody to a C albicans cell wall antigen in the diagnosis of candidiasis or invasive candidiasis is disclosed.

Abstract: The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars.

Abstract: The present invention relates to the use of an assay and product for rapid detection of fungi in a variety of samples suspected of containing fungi, particularly swab samples from the human vaginal area, but also in other environments such as in food and feeds. The product of the invention is suitable for use in a variety of different environments, including in clinical settings, at the point of care, and by patients themselves (bedside kit).

Abstract: The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides.

Abstract: A composition comprising lactic acid and lactoferrin and/or a peptide fragment thereof, for the treatment and/or prophylaxis of conditions in the urogenital tract, is disclosed. Also disclosed is the use of such a composition for the preparation of a medicament for the treatment and/or prophylaxis of conditions in the urogenital tract, as well as a method for treatment thereof.

Abstract: The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides.

Abstract: The use of an antibody to a C albicans cell wall antigen or to a solubilized phosphopeptidomannan (PPM) fraction of the cell wall of C albicans, or preferably a combination of an IgG2 antibody to a phosphopeptidomannan (PPM) fraction of the cell wall of C albicans, and an IgG1 or IgG3 antibody to a C albicans cell wall antigen in the diagnosis of candidiasis or invasive candidiasis is disclosed. Also diagnostic tests are disclosed.

Abstract: Monoclonal antibodies reactive with ?(1-3)-glucans are disclosed. More precisely, two monoclonal antibodies, B3B and A10A, reactive with ?(1-3)-glucan and/or ?(1-3) (1-6)-glucan associated epitopes in free, non-associated form, and/or in cell wall fragments of Candida and Cryptococcus are disclosed. Further, A10A is also reactive with a ?(1-6) (1-3)-glucan epitope present on the intact cell surface of C. albicans, C. parapsilosis, C. krusei, C. glabrata and/or C. neoformans. The antibodies can be used for the detection of free, cell wall associated, and/or cell surface associated ?(1-3) glucans utilizing immunoassays or immunohistology for the laboratory diagnosis of fungal infections. They may be used also for detection of airborn mould, or mould present in dust, water, or in any other component.